Global Presbyopia Market Size study, By Symptoms (Eye Strain, Headaches, Fatigue, Blurred Vision, Others), By Treatment (Eyeglasses, Contact Lenses, Refractive Surgery, Others), and Regional Forecasts 2022-2028

Global Presbyopia Market Size study, By Symptoms (Eye Strain, Headaches, Fatigue, Blurred Vision, Others), By Treatment (Eyeglasses, Contact Lenses, Refractive Surgery, Others), and Regional Forecasts 2022-2028

Global Presbyopia Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Presbyopia is a condition in which an individual’s eyes lose their ability to focus on nearby objects. The growing investment in healthcare infrastructure, rising number of geriatric populations, and increasing incidences of presbyopia are primary factors contributing to the market growth on a global scale. For instance, as per the Department of Economic and Social Affairs, in 2019, the global population aged 65 and more is accounted for around 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. Therefore, the geriatric population is more prone to vision loss and aging adults (age 40 or more years) are offering various growth prospects to the market, which stimulate the market growth across the globe. However, the dearth of skilled professionals and unavailability of advanced healthcare infrastructure in emerging economies impede the growth of the market over the forecast period of 2022-2028. Also, the rising investment in the advancing of innovative technologies and increasing research and development activities are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Presbyopia Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing spending on healthcare facilities, along with increasing investment in technological developments for advanced presbyopia treatment. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing geriatric population, as well as, rising availability of better healthcare facilities, would create lucrative growth prospects for the Presbyopia Market across the Asia-Pacific region.

Major market players included in this report are:
Visus Therapeutics
Novartis
Lenz Therapeutics
Arctic Vision
Orasis
Ocuphire Pharma
Presbia PLC
MAG Optics Inc.
PixelRo
LensGen

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Symptoms:
Eye Strain
Headaches
Fatigue
Blurred Vision
Others
By Treatment:
Eyeglasses
Contact Lenses
Refractive Surgery
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Presbyopia Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Visus Therapeutics
Novartis
Lenz Therapeutics
Arctic Vision
Orasis
Ocuphire Pharma
Presbia PLC
MAG Optics Inc.
PixelRo
LensGen

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.